4-Methylmorpholine → HCID 45278720, compound
Reaction equation
[CH3:1][N:2]1[C:6]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[CH:5][C:4]([C:13]([OH:15])=O)=[C:3]1[CH3:16].Cl.Cl.[Cl:19][C:20]1[CH:21]=[C:22]([N:26]2[CH2:31][CH2:30][N:29]([CH2:32][CH2:33][CH2:34][NH2:35])[CH2:28][CH2:27]2)[CH:23]=[CH:24][CH:25]=1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1>C(Cl)Cl.CO>[Cl:19][C:20]1[CH:21]=[C:22]([N:26]2[CH2:27][CH2:28][N:29]([CH2:32][CH2:33][CH2:34][NH:35][C:13]([C:4]3[CH:5]=[C:6]([C:7]4[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=4)[N:2]([CH3:1])[C:3]=3[CH3:16])=[O:15])[CH2:30][CH2:31]2)[CH:23]=[CH:24][CH:25]=1Participants
8
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
To the mixture of 1,2-Dimethyl-5-phenyl-1H-pyrrole-3-carboxylic acid (100 mg, 0.46 mmol) and 3-(4-(3-chlorophenyl) piperazin-1-yl)propan-1-amine dihydrochloride (152 mg, 0.46 mmol) in methylene chloride (5 ml) was added EDCI (178 mg, 0.92 mmol), HOBT (130 mg, 0.9 mmol) and NMM (0.3 ml, 1.8 mmol) continuously. After stirring for 1 day at room temperature, MeOH was added to the resulting solution, and filter off. After evaporation under reduced pressure, the residue was purified by reverse phase preparative HPLC to provided title compound (149 mg, 71%) as white solid.
Workup
- filtrationfilter off
- customAfter evaporation under reduced pressure
- customthe residue was purified by reverse phase preparative HPLC
Sources & evidence
- ORD record
- ord-bec662023f5141fd9823607c32997ef6
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08895558B2
Reaction notes
Loading…